Shibuya-ku, Tokyo, Japan, Japan, Aug 19, 2021, 01:41 /Comserve / -- Key Vendors: AbbVie, Inc., Amgen, Inc., F. Hoffmann-La Roche Ltd., Bristol–Myers Squibb, Johnson and Johnson, Merck & Co., Inc.
Global Immunotherapy Drugs Market – Drivers, Restraints, Opportunities, Trends, and Forecast up to 2025
[104 pages report] This market research report includes a detailed segmentation of the global immunotherapy drugs market by drug type (monoclonal antibodies, vaccine, non-specific immunotherapies, adaptive cell therapy, and others), by treatment area (cancer, inflammatory and autoimmune disease, infectious disease, and others), by regions (North America, Europe, Asia Pacific, and Rest of the World).
Request to Fill The Form To get Sample Copy of This Report: https://www.sdki.jp/sample-request-107451
"The Final Report will cover the impact analysis of COVID-19 on this industry (Global And Regional Market)."
Key Vendors:
• AbbVie, Inc.
• Amgen, Inc.
• F. Hoffmann-La Roche Ltd.
• Bristol–Myers Squibb
• Johnson and Johnson
• Merck & Co., Inc.
Overview of the Global Immunotherapy Drugs Market
Infoholic’s market research report predicts that the “Global Immunotherapy Drugs Market” will grow at a CAGR of 12.5% during the forecast period. The market has witnessed steady growth in the past few years, and the introduction of novel products has increased the acceptance of immunotherapy drugs in the market. The market is fueled by an upsurge in the incidence of lifestyle and chronic disease globally, reduction in disease recurrence, increasing product approval, and high preference for immunotherapy over traditional chemotherapy.
Table of Content
1 Industry Outlook 9
1.1 Industry Overview 9
1.1.1 Global Driver for Pharmaceutical Demand 12
1.1.2 R&D Pipeline in Pharmaceutical Industry 12
1.1.3 Top Pharma Drugs by Sales (In $Million) 13
1.2 Industry Trends 14
2 Report Outline 16
2.1 Report Scope 16
2.2 Report Summary 16
2.3 Research Methodology 17
2.4 Report Assumptions 18
3 Market Snapshot 19
3.1 Market Definition – Infoholic Research 19
3.2 Benefits of Immunotherapy 19
3.3 Segmented Addressable Market (SAM) 19
3.4 Trends of the Immunotherapy Drugs Market 20
3.5 Related Markets 21
3.5.1 Human Insulin 21
3.5.2 Oncology Drugs 22
4 Market Outlook 24
4.1 List of Cancer Immunotherapy Drugs Approved (2016- April 2019) 24
4.2 Market segmentation 26
4.3 PEST Analysis 27
4.4 Porter 5 (Five) Forces 28
5 Market Characteristics 29
5.1 DRO – Global Immunotherapy Drugs Market Dynamics 29
5.1.1 Drivers 29
5.1.1.1 High preference of immunotherapy over traditional chemotherapy 29
5.1.1.2 Growing incidence of lifestyle and chronic diseases 30
5.1.2 Opportunities 31
5.1.2.1 Emergence of biosimilars 31
5.1.2.2 Increasing opportunities in the emerging market 31
5.1.3 Restraints 32
5.1.3.1 High immunotherapy treatment costs 32
5.1.3.2 Complex manufacturing process 32
5.2 DRO – Impact Analysis 32
5.3 Key Stakeholders 33
Request to Fill The Form To get Sample Copy of This Report: https://www.sdki.jp/sample-request-107451
"The Final Report will cover the impact analysis of COVID-19 on this industry (Global And Regional Market)."
Benefits – The report provides complete details about the related sub-segments of the immunotherapy drugs market. Through this report, the key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives toward the disease management in the upcoming years along with details of the existing pure-play companies and new players entering the market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders in order to expand their business and capture the revenue in specific verticals, and to analyze before investing or expanding the business in this market.
The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.
For more information, please contact:
Lauren BrownShibuya Data Count
Email: sales@sdki.jp
Tel: + 81 50 50509159
Related Links
https://www.sdki.us/